Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2).
Al-Naamani N, Krowka MJ, Forde KA, Krok KL, Feng R, Heresi GA, Dweik RA, Bartolome S, Bull TM, Roberts KE, Austin ED, Hemnes AR, Patel MJ, Oh JK, Lin G, Doyle MF, Denver N, Andrew R, MacLean MR, Fallon MB, Kawut SM; , for the Pulmonary Vascular Complications of Liver Disease Study Group.
Al-Naamani N, et al. Among authors: krok kl.
Hepatology. 2021 Feb;73(2):726-737. doi: 10.1002/hep.31314. Epub 2020 Sep 29.
Hepatology. 2021.
PMID: 32407592
Free PMC article.